Navigation Links
New BioTrends Report Explores Anticipated Treatment Pattern Shifts Expected with the Proposed Bundled Payment Structure Planned for 2011

EXTON, Pa., July 28 /PRNewswire/ -- BioTrends Research Group, Inc. recently released its baseline report assessing awareness of the Centers for Medicare and Medicaid Services (CMS) proposed dialysis bundled payment plan among Medical Directors and Renal Administrators in dialysis units across the country. Approximately half of the respondents were affiliated with large dialysis chains (i.e. Fresenius, DaVita, DCI) with the other half operating in small-to-medium sized dialysis chains, independent units, and hospital based units.

The report, based on survey responses from 160 Medical Directors and 117 Renal Administrators and supplemented with qualitative interviews conducted with key stakeholders (dialysis organization executives, renal organizations, key opinion leaders on the subject of bundling), examines awareness of the proposed bundle components, anticipated changes in practice management, the degree of control in decision making Medical Directors and Renal Administrators expect to have, and their overall concerns with bundle implementation. Specific impact on the utilization of ESAs, IV iron, Vitamin D, phosphate binders, and Amgen's Sensipar is explored as it relates to how likely various scenarios are and whether or not they are in the best interest of dialysis patients.

Although exact details of the bundled payment system have yet to be finalized and made official, Medical Directors and Renal Administrators are clearly concerned about the impact of these changes on the fiscal health (and viability) of their units as well as the potential impact on patient outcomes. The most valuable sources of information on bundling were noted as the Renal Physician's Association for Medical Directors and the ESRD Networks for Renal Administrators.

The full report is available for purchase at A follow up wave of this report is planned in early 2010 after additional details on the bundle legislation have been released.

About BioTrends Research Group, Inc.

BioTrends Research Group, Inc. ( provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.

All company, brand, or product names contained in this document may be trademarks of their respective holders.

SOURCE BioTrends Research Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
2. BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis
3. New Report by BioTrends Research Group to Highlight the Launch of SIMPONI(R) (golimumab)
4. Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
5. BioTrends Announces a New Syndicated Report Series, LaunchTrends(TM): Feraheme
6. Virginia Tech Report Has National Importance
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
9. Haemacure Reports Third Quarter 2007 Results
10. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
11. Biotech Finishes on a High in August, Burrill Report Says
Post Your Comments:
(Date:11/30/2015)... ... ... anxiety, illness, infection or even a need for eyeglasses can sometimes cause headaches, but ... pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, Florida, said that while headaches ... headaches that don’t go away, that don’t have any other reason, even after you’ve ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... driverless vehicle experience this summer, ushering in a new era of publicly accessible ... and electric shuttle, will continue to offer guests an up-close look at the ...
(Date:11/30/2015)... ... 30, 2015 , ... The presidential race normally deals with political issues of ... a national news story when Donald Trump makes disparaging remarks about Hillary Clinton’s hairstyle? ... than anyone wants to admit when it comes to how people are viewed by ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Catalyst continuing education course in Dallas, TX, on January 29 and 30, 2016. ... to improve the functions of their practices, to learn how to better succeed ...
(Date:11/30/2015)... ... November 30, 2015 , ... A ... of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of ... Their study showed that small molecule analogs that target the functions of SecA, ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 iCAD, Inc. (Nasdaq: ... its latest solutions for advanced image analysis and ... at the Radiological Society of North American (RSNA) ... from November 29 to December 4, 2015. ... iReveal®, an automated breast density assessment solution, PowerLook® ...
(Date:11/30/2015)... 30, 2015 Booth #4303 – The Imaging Components ... exhibit a broader array of products in a new booth ... North America in Chicago ... will feature X-ray components "At the Heart of Imaging." Products ... products from Varian,s Claymount brand, and computer-aided diagnostic software from ...
(Date:11/30/2015)... , Nov. 30, 2015  Novartis will demonstrate ... the 57 th American Society of Hematology (ASH) ... and myelomas as well as supportive care, including key ... to personalized cell therapies. The ASH Annual Meeting will ... . Novartis Oncology . "We will ...
Breaking Medicine Technology: